(1 - 14 von 20
)
4503.T - | Stock Price & Latest News | Reuters
www.reuters.com
Chairman of the Board, Chairman of the Board of Directors, Representative Director. Kenji Yasukawa. President, Chief Executive Officer, Representative Director.
Otsuka Chemical Succeeded Part of the Cefixime Business from Astellas...
financialpost.com
President, : Kenji Yasukawa, President and CEO. Head Office, : , Nihonbashi-Honcho, Chuo-Ku, Tokyo , Japan. Employees ...
Seagen - Seattle Genetics and Astellas Announce Submission of...
investor.seagen.com
16, Seattle Genetics, Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa , Ph.D., “Astellas”) ...
Astellas Announces Acquisition of Quethera
www.prnewswire.co.uk
PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa,Ph.D., "Astellas") and Quethera Limited (CEO: Peter ...
Astellas Receives Approval of EVRENZO® (roxadustat) in Japan for the...
investor.fibrogen.com
(TSE: 4503, President and CEO: Kenji Yasukawa , Ph.D., "Astellas") and FibroGen, Inc. (Nasdaq: FGEN, CEO: Enrique Conterno , " FibroGen ...
Astellas Receives U.S. FDA Fast Track Designation for ASP5354, an...
newsroom.astellas.us
(TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas" ) announced today that the United States ("U.S.") Food and Drug ...
Astellas Pharma Names Americas Ops President - Contract Pharma
www.contractpharma.com
Barretto-Ko to lead the company's North and South America operations
Astellas Launches DigiTx Partners, a Digital Health Investment...
www.digitxpartners.com
... impacting patients' healthcare and wellness,” said Kenji Yasukawa, Ph.D., Senior Vice President and Chief Strategy Officer, Astellas.
Astellas buys eye gene therapy biotech Quethera for $109m -pharmaphorum.com › news › astel...
pharmaphorum.com
Kenji Yasukawa, president and CEO at Astellas, said: “This acquisition demonstrates Astellas' commitment to proactively incorporate ...
Astellas gains three cancer drugs with $405m Potenza buy -
pharmaphorum.com
Astellas is to buy biotech Potenza The…utics after the companies spent more than three years working together on cancer immunotherapies.
Astellas bulks up immuno-oncology pipeline with $665m Xyphos deal -...
www.pmlive.com
... of next-generation cancer immuno-therapy using new modalities/technologies, ” said Kenji Yasukawa, president and CEO of Astellas.
Changing Tomorrow Day
www.3blmedia.com
Changing Tomorrow Day Marks Astellas’ Fifth Annual Global Service Initiative More than 6,000 employees...
Astellas and Welldoc Partnership - Welldoc | Chronic Care Platform
www.welldoc.com
Develop and commercialize digital health solutions globally for multiple the…utic areas, including in Japan for diabetes patients
sortiert nach Relevanz / Datum